PolarityTE, Inc. Ann
PolarityTE, Inc. Announces the Addition of Ramses Erdtmann, Managing Partner at Point Sur Investors and Former Executive at Pharmacyclics, and David Seaburg, Managing Director at Cowen and CNBC Contributor, to the Board of Directors
August 09, 2018 08:30 ET | PolarityTE, Inc.
SALT LAKE CITY, Aug. 09, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of...
PolarityTE, Inc. Ann
PolarityTE, Inc. Announces Alain Adam as Vice President of Sales
July 31, 2018 08:00 ET | PolarityTE, Inc.
SALT LAKE CITY, July 31, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL) today announced the appointment of Alain Adam as Vice President of Sales. Mr. Adam will lead the company’s continued...
PolarityTE, Inc. Pro
PolarityTE, Inc. Provides Commercial Update
July 25, 2018 09:00 ET | PolarityTE, Inc.
SALT LAKE CITY, July 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company, today announced an update on the Company’s...
PolarityTE Adds Pete
PolarityTE Adds Peter Cohen, Former Board Member of the NYSE and Chairman and CEO of Cowen Inc., to the Board of Directors
July 02, 2018 08:00 ET | PolarityTE, Inc.
SALT LAKE CITY, July 02, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL) today announced that Peter Cohen will join PolarityTE’s Board of Directors. Mr. Cohen is well known within the...
PolarityTE Provides
PolarityTE Provides Update on Key Opinion Leader Event and Addresses Misleading Report
June 27, 2018 08:00 ET | PolarityTE, Inc.
SALT LAKE CITY, June 27, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL) today announced that the Company hosted a successful meeting of key opinion leaders in New York City on June 25,...
PolarityTE Added to
PolarityTE Added to Russell 3000® and Russell 2000® Indexes
June 25, 2018 07:30 ET | PolarityTE, Inc.
SALT LAKE CITY, June 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by...
UPDATE - PolarityTE
UPDATE - PolarityTE Appoints Paul Mann of Highbridge Capital to Chief Financial Officer
June 21, 2018 08:32 ET | PolarityTE, Inc.
SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL) today announced that Paul Mann of Highbridge Capital Management is the new Chief Financial Officer of the Company....
PolarityTE Appoints
PolarityTE Appoints Paul Mann of Highbridge Capital to Chief Financial Officer
June 21, 2018 08:00 ET | PolarityTE, Inc.
SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL) today announced that Paul Mann of Highbridge Capital Management is the new Chief Financial Officer of the Company...
PolarityTE Provides
PolarityTE Provides Corporate Update on Company Progress
June 18, 2018 08:00 ET | PolarityTE, Inc.
SALT LAKE CITY, June 18, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients...
PolarityTE Announces
PolarityTE Announces Pricing of Public Follow-on Offering of Common Stock
June 05, 2018 08:49 ET | PolarityTE, Inc.
SALT LAKE CITY, June 05, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients...